NCT01410981View on ClinicalTrials.gov

Prognostic Potential of Cell Surface Markers and Pim Kinases in Multiple Myeloma

CompletedOBSERVATIONAL
Enrollment

73

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Multiple Myeloma
Trial Locations (1)

29425

Medical University of South Carolina, Charleston

Sponsors

Collaborators (1)

Genentech, Inc.
All Listed Sponsors
collaborator

Genentech, Inc.

INDUSTRY

lead

Medical University of South Carolina

OTHER

NCT01410981 - Prognostic Potential of Cell Surface Markers and Pim Kinases in Multiple Myeloma | Biotech Hunter | Biotech Hunter